NCT06238661View on ClinicalTrials.gov

Prostate Cancer Screening: a Pilot Study

NAEnrolling by invitationINTERVENTIONAL
Enrollment

4,500

Participants

Timeline

Start Date

February 17, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Urology visit with Risk Calculator and MRI

Patients with PSA ≥3 ng/ml will undergo urology visit with risk calculator and MRI assessment of the prostate

Trial Locations (1)

10060

Fondazione del Piemonte per l'Oncologia, Candiolo

All Listed Sponsors
collaborator

San Luigi Gonzaga Hospital

OTHER

collaborator

Epidemiology and Screening Unit - CPO, Turin, Italy

UNKNOWN

collaborator

ASL TO5

UNKNOWN

lead

Fondazione del Piemonte per l'Oncologia

OTHER